111111111111111111111111111111111111111111111111111111111111111111111111111111111
Egis World
Egis´ products are sold to 100 countries.
Csaba Poroszlai is confirmed CEO of the company by the Board of Directors of Egis.
Balázs Vándor is appointed to the position of the Company’s Chief Financial Officer. More
Collaboration agreement signed between Egis and the Uzbek Medicines Authority
Egis and the Uzbek Medicines Authority have signed a collaboration agreement in Tashkent to improve pharmaceutical regulations and access to medicines in Uzbekistan.
Dr Csaba Pácz confirmed as Commercial Director of Egis Group
The selection process for the position of Egis Group’s Commercial Director has been closed. As a result, dr Csaba Pácz remains head of the Commercial Directorate.
Egis Pharmaceuticals PLC for Ukraine
Since the very beginning of the war in Ukraine, Egis Pharmaceuticals PLC has been committed to helping and supporting those in need in all possible ways.
Egis Pharmaceuticals PLC helps its employees from Kyiv and offers further humanitarian aid worth more than HUF 100 million
Egis has been present in Ukraine for more than 20 years – its representative office has become an important player for supplying the country with medicines since its opening in 1999. Egis helps its colleagues in Ukraine in every way it can and provides humanitarian aid to Ukrainian patients in the current situation.
Other channels
Our mission is to serve people with all of our skills, ensuring that they live a long and healthy life
In the 2022/2023 business year, the company’s product portfolio consisted of 653 products
In the 2022/2023 business year, we spent EUR 48 million on research and development
Healthcare and sharing knowledge are in the heart of our CSR activities
Our highlighted past and future events you shouldn't miss
Quick news
Your browser is out of date. Please, use an updated version!